Company: BLTE
Filing Date: 2025-03-17
Form Type: 20-F
Source: 0001410578-25-000356
Chunk: 15

Company: BELITE BIO, INC
Filing Date: 2025-03-17
Form: 20-F
Item: Item 19
Chunk 15
---
 Exhibit 10.14 from our registration...  
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  4.13           Fifth Amendment to Exclusive License Agreement by and between Belite Bio, Inc and The Trustees of Columbia University in The City of New York dated February 4, 2022 ( incorporated by reference ...  
  4.15           First Amendment to LBS-008 Research and Development Services Agreement by and between Belite Bio, Inc and Lin BioScience, Inc. dated February 23, 2022 ( incorporated by reference to Exhibit 10....  
  4.16           Sales Agreement by and between Belite Bio, Inc and SVB Securities LLC and Cantor Fitzgerald & Co. dated June 16, 2023 (incorporated by reference to Exhibit 1.1 from our registration statement o...  
  4.17           Underwriting Agreement by and between Belite Bio, Inc and SVB Securities LLC and Cantor Fitzgerald & Co., as representatives of the underwriters named therein, dated May 30, 2023 (incorporated ...  
  4.18*          Belite Bio, Inc Severance and Change in Control Plan                                                                                                                                                  
  4.19           Securities Purchase Agreement by and between Belite Bio, Inc and an institutional investor dated April 25, 2024 (incorporated by reference to Exhibit 1.1 from our registration statement on Form...  
  4.20           Form of Inducement Offer Letter Agreement by and between Belite Bio, Inc and an institutional investor dated November 3, 2024 (incorporated by reference to Exhibit 10.1 from our registration st...  
  4.21           Securities Purchase Agreement by and between Belite Bio, Inc and an institutional investor dated February 5, 2025 (incorporated by reference to Exhibit 1.1 from our registration statement on Fo...  
  4.22           Placement Agency Agreement by and between Belite Bio, Inc and Titan Partners Group LLC, a division of American Capital Partners, LLC, as exclusive placement agent, dated February 5, 2025 (incor...  
  8.1*           List of subsidiaries of the Registrant                                                                                                                                                                
  11.1           Code of Business Conduct and Ethics of the Registrant (incorporated hereby reference to Exhibit 99.1 to the